Demographic and Clinical Parameters in the 10 Patients of the Study Population
| Parameter | Data |
| Median age (y) | 68.5 (range, 52–78) |
| Mean duration of cancer (mo) | 30 (range, 3–120) |
| Type of cancer (n) | |
| Lung | 4 |
| Prostate | 3 |
| Breast | 2 |
| Esophagus | 1 |
| Prior radiotherapy (n) | 6 (60%) |
| Median time since last radiotherapy (mo) | 8 (range, 4–10) |
| Prior chemotherapy (n) | 4 (40%) |
| Median time since last chemotherapy (mo) | 18 (range, 2–34) |
| Prior radionuclide therapy (n) | 6 (60%) |
| Median time since last radionuclide therapy (mo) | 8 (range, 5–27) |
| Median baseline scores | |
| Skeleton-based pain | 8.44 (range, 7.2–9.8) |
| Mobility | 2.99 (range, 2–4) |
| Karnofsky performance | 45 (range, 40–50) |
| Median 4-wk scores | |
| Skeleton-based pain | 5.73 (range, 4.8–6.9) |
| Mobility | 1.3 (range, 1–2) |
| Karnofsky performance | 69 (range, 60–80) |
| Median 8-wk skeleton-based pain score | 3.82 (range, 3.3–4.8) |
| Median 12-wk skeleton-based pain score | 1.71 (range, 1.2–2.2) |